Bowels Behaving Badly BAHSHE Conference 05-07-2005.

Slides:



Advertisements
Similar presentations
Diagnostic Work-up. There is no specific laboratory or imaging test to diagnose irritable bowel syndrome. Currently the diagnosis of IBS relies on meeting.
Advertisements

Irritable bowel syndrome in adults
Irritable Bowel Syndrome Dr Bruce Davies Sept 2001Bruce Davies2 Introduction First described in % of patients present
Management of Inflammatory bowel disease 8/12/10.
Investigation of Diarrhoea IBD IBS Sarah Lean Consultant Gastroenterologist Hillingdon.
It’s A Gut Feeling: Abdominal Pain in Children David Deutsch, MD Pediatric Gastroenterology Rockford Health Physicians.
Irritable Bowel Syndrome
Irritable Bowel Syndrome John McLaughlin Clinical Lecturer/Consultant Gastroenterologist Hope Hospital, Salford.
IBS or IBD: a N.I.C.E. Way to Tell
Ulcerative Colitis.
Overview of Irritable Bowel Syndrome
IRRITABLE BOWEL SYNDROME (IBS)
IBS Irritable Bowel syndrome Prince Sattam Bin AbdulAziz University College Of Pharmacy Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department.
Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.
Irritable Bowel Syndrome Sam Thomson 3 rd November 2010.
IRRITABLE BOWEL SYNDROME
Management of irritable bowel syndrome (IBS) WORKSHOP Dimitris Karanasios.
Irritable Bowel Syndrome
Irritable Bowel Syndrome Rahul Gladwin, MS3 University of Health Sciences Antigua School of Medicine rahul[AT]rahulgladwin.com.
Irritable Bowel Syndrome Biol E-163 TA session 12/18/06.
Irritable bowel syndrome in adults NICE Clinical Guideline 61 – February 2008.
IBS In The Elderly Monica J. Cox ARNP-BC, MSN, MPH Geriatric Nurse Practitioner G.I. Nurse Practitioner Borland-Groover Clinic Jacksonville, Florida.
Dr. Abdulrahman Aljebreen.  To know the ◦ pathophysiology, ◦ clinical features and ◦ how to diagnose and ◦ How to manage patients with IBS.
Dyspepsia. What is dyspepsia? ‘pain or discomfort related to eating or drinking that can be attributed to the upper gastro-intestinal tract’
Irritable Bowel Syndrome 1481 Nadeem Khan March 2, 2015.
Presented By: Asha Davidson and Asmani Patel
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
Focus on Irritable Bowel Syndrome (IBS)
AM Report 6/30/10 Justin Crocker PGY-3. Functional Abdominal Pain Chronic pain disorder that is not explainable by a structural or metabolic disorder.
Dyspepsia Summary of the Today Session.
IRRITABLE BOWEL SYNDROME
Constipation: treatment in primary care, when to refer and novel therapies.... Lee Dvorkin Consultant General, Colorectal & Laparoscopic Surgeon Spire.
Irritable Bowel Syndrome By: Rocco Paolino. Definition A combination of intermittent abdominal pain, constipation and/or diarrhea.
Direct Access Flexible Sigmoidoscopy
Causes of Constipation. Main Point Constipation is a SYMPTOM Constipation is not a diagnosis.
1 Ellora Islam Jodie Ly Tony Davi Sonaiya Kelley.
1- Irritable Bowel Syndrome (IBS) 2- Constipation
Irritable Bowel Syndrome. A functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in the absence of detectable.
1. What is the most common cause of constipation? A.Pelvic floor dyssynergia B.Slow transit C.Functional D.Mechanical obstruction.
Management of Irritable Bowel Syndrome (IBS) in Family Medicine Meera Kaur, PhD, RD, CDE Assistant Professor, Family Medicine University of Manitoba, Canada.
Chapter -5 Somatoform Disorder. General characteristics  Physical signs and symptoms lacking a known medical basis in the presence of psychological factors.
Habit disorders Dr. Ibrahim Khasraw Lecturer in Pediatrics School of Medicine Sulaimani University of.
ULCERATIVE COLITIS. Ulcerative colitis is an idiopathic chronic inflammatory disease of the colon that follows a course of relapse and remission. In a.
Are patients with chronic diseases a new challenge to general practice? Patients with irritable bowel syndrome in general practice Patients with irritable.
Definition Signs & symptoms Treatment Root of the disease.
Changes in bowel movement-IBS Mohammed Alwahibi Khalid Alsadhan Walid Alkhamis.
Change in Bowel Movement Mohammed Abaalkhail Muath Alsoliman Badr Almosned.
IBS (Irritable Bowel Syndrome)
IRRITABLE BOWEL SYNDROME Barbara L. Slee, M.D.. IBS Epidemiology and pathophysiology Symptoms and signs of Dx Appropriate Work-up Treatment.
POLYPS CHOLORECTAL CANCER M. DuBois Fennal, PhD, RN, CNS.
Kingdom of Saudi Arabia Alghad collages –Tabuk girls.
Shad Johnson MPAS, PA-C Southeast Idaho Gastroenterology.
FUNCTIONAL (NON-ULCER) DYSPEPSIA TUCOM Internal Medicine 4th class Dr
Irritable Bowel Syndrome
Irritable Bowel Syndrome
1- Irritable Bowel Syndrome (IBS) 2- Constipation
Changes in bowel movements (IBS)
IRRITABLE BOWEL SYNDROME
Changes in bowel movements (IBS)
Focus on Irritable Bowel Syndrome (IBS)
Presenting with IBS symptoms, baseline assessment.
Irritable Bowel Syndrome (IBS)
IRRITABLE BOWEL SYNDROME
A middle-aged man is chronically preoccupied with his health
ODS & STARR Procedure Brij B. Agarwal
CHANGES IN BOWEL MOVMENTS (IBS)
Drugs for the treatment of irritable bowel syndrome (IBS)
IRRITABLE BOWEL SYNDROME
Irritable Bowel Syndrome (IBS)
Presentation transcript:

Bowels Behaving Badly BAHSHE Conference

Functional Bowel Disorders Classification and Diagnostic Criteria Epidemiology Pathophysiology Role of psychosocial factors. Diagnosis Treatment recommendations When or if to refer.

Definitions No objective biological markers exist. Spectrum of FGD defined by symptoms in the absence of structural pathology. Manning Criteria Rome I and II

Manning criteria Pain relieved by defaecation Looser stools with pain More frequent stools with pain Abdominal distension Passage of mucus Sensation of incomplete evacuation

Rome II criteria At least 12 weeks or more in preceding 12months of abdominal discomfort or pain with 2 of the following –Relieved by defaecation –Onset associated with change in frequency of stool –Onset associated with change in consistency of stool. Supportive features

Altered stool frequency Altered stool form Altered stool passage (straining, urgency, incomplete evacuation) Passage of mucus Bloating

Prevalence of IBS as judged by Manning Criteria No of symptoms Male Female

Epidemiology Prevalence –14-24% women, 5-19% men Any age but decrease after 60 15% seek medical attention 25-50% of all referrals to gastroenterologists 2 nd highest cause of work absenteeism Direct cost in USA $1.7billion in 2000

Social Impact Social activities restricted Fear of travel Work absenteeism (14.8 days per year v 8.7) Anxiety Extreme lethargy In extreme virtually housebound. Unnecessary surgery

Aetiology Gastrointestinal motility Visceral hypersensitivity Psychological discomfort Emotional distress Post-infectious Post-surgical Food intolerance

Gastrointestinal motility Basal motility is not consistently altered in IBS patients Gastro-colonic response in IBS results in increased duration of rectosigmoid contractions, compared with controls. Stress and anger increase colonic motility in IBS. In general motility studies are inconsistent and the normal range is wide.

Visceral Hypersensitivity Patients with bloating do not have increased quantities of gas in GI tract. Many have lowered tolerance of balloon distension in rectum (and elsewhere). Repetitive stimulation of the sigmoid can induce visceral hyperalgesia in IBS patient but not in controls. Stress and meals increase sigmoid contractions and hence may induce transient hyperalgesia in IBS.

Visceral Hypersensitivity BUT no increased visceral hypersensitivity is found in IBS “non-presenters” Visceral hypersensitivity is also found in patients with other chronic pain syndromes. Recent work involving functional MRI suggests that visceral hypersensitivity probably results from altered CNS processing of sensory information.

Psychosocial Factors IBS patients referred to hospital have an increased prevalence of anxiety, depression, phobias and somatisation. 25% think they have cancer. Increased history of abuse in this group (20- 30%). Non-presenters have same prevalence of these as controls. Psychological distress thus appears to influence experience of IBS rather than cause it.

Stress Acute stress mimicked by CRF infusion –Increased colon motility –Decreased upper gut motility –Induces abdominal pain Chronic stress –>50% link onset to stressful life-event –In one study 60% of patients without chronic stressor improved compared with 0% with.

Postinfectious IBS found in 20-30% after acute bacterial infection RR of IBS after proven infection =14 (nested case-control of 318 pts with bacterial gastroenteritis and 584,308 controls) Risk increased if long duration initial attack, female, younger age.

Possible mechanism Mucosal damage particularly with invasive organisms causing neural injury. Bile-salt malabsorption. Reduced disaccharidase activity. Altered bacterial flora Increased enteroendocrine cells. Unmasked IBD.

Postsurgical Hysterectomy, cholecystectomy, appendicectomy and any other abdomino- pelvic surgery may precipitate IBS. Prospective studies show about 10% develop new bowel symptoms within 6 months, usually constipation predominant IBS.

Mechanisms include Altered bowel flora after antibiotics, Neural damage with subsequent aberrant regeneration. Bile salt diarrhoea. Misdiagnosis of original problem.

Diet Intolerance –30-60% have specific intolerance –Wheat, dairy, potato, corn, coffee, onions, beef, oats, white wine Allergy –Much less common –Asthma, urticaria, angioedema –RAST or pinprick

Diagnosis in General Practice Careful detailed history over time Examination including rectal examination where relevant. If typical features, <45y, no alarm symptoms then make a positive diagnosis –Especially if female, frequent attender, long history. If atypical or short history then screening investigations +/- referral.

When to refer Older patient presenting for first time. Atypical symptoms –Bleeding –Weight loss –Nocturnal symptoms –Anaemia Reassurance in patients with longstanding FGD but with new or worse symptoms.

Diagnosis in Hospital Cannot rely on symptom criteria alone History Examination Tests

History Onset Alarm symptoms Family history Diet Travel Systemic symptoms Drugs Stool characteristics

Examination Disparity between well looking patient and desperate symptoms. Signs of systemic illness eg thyroid Abdominal mass Rectal examination, sphincter tone.

Investigations FBC, ESR, CRP TFTs Stool microbiology Sigmoidoscopy and biopsy Hydrogen breath test

Using these tests 1452 IBS patients in US study –6% thyroid disease –1% occult IBD –20% lactose intolerance Other logical screening tests include –Anti-endomysial antibodies –Albumin –Calcium

Further tests Colonoscopy if>45y or FH Barium enema Barium follow through Ultrasound rarely helpful

Treatment of IBS General principles Therapeutic relationship Patient education Dietary modification Psychological approaches Simple drugs Complicated drugs

General Principles No known cure but “benign disease” Focus on symptom relief Alleviate concerns Simple explanation Consider hidden agenda Identify exacerbating factors Identify psychiatric comorbidity

Dietary Modification Fibre Lactose avoidance Avoidance of foods that increase flatulence –Beans, onions, carrots, sprouts, prunes etc Modified exclusion diet ( eg as per Hunter), >50% remission in 2 studies.

Modified Exclusion Diet Meat Fish Fruit (not citrus) Vegetables (not sweetcorn, onion, potato) Rice

Psychological Therapies Relaxation Biofeedback Hypnotherapy Cognitive Behavioural therapy. Psychiatry

Simple Drugs –symptom based Antispasmodics –Antimuscarinics- dicyclomine, hyoscine –Others- alverine, mebeverine, peppermint –Meta-analysis of 23 controlled trials found a small but significant benefit (53 v 41%) –Mebeverine failed to show improvement in pain but did result in global improvement. –Dicyclomine was best for pain.

Simple Drugs Loperamide Codeine Cholestyramine Laxatives

Antidepressants Several trials show benefit of low and high dose antidepressants. Tricyclics can normalise rapid transit times and modify visceral sensation. SSRIs can accelerate transit

New Drugs 5HT3 antagonists decrease diarrhoea 5HT4 antagonists decrease constipation Alosetron reduced diarrhoea in females with IBS. Tegaserod 5HT4 partial agonist, decrease colonic transit time.

Prognosis Incidence of new significant diagnosis is low –One study 0/104 at 5y –Another 3/112 at 5yrs (1 ca pancreas, 1 thyrotoxicosis, 1 gallstones) Symptoms persist in 30-95% in various studies.

Treatment Summary Positive Diagnosis Listen Explain and Reassure Dietary Advice Psychological considerations and treatment Pharmacological Treatment